Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 44.47
-1.79 (-3.87%)
At close: May 12, 2026
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 7.73 billion as of May 12, 2026. Its market cap has increased by 56.97% in one year.
Market Cap
7.73B
Enterprise Value
6.50B
Revenue
887.21M
Ranking
n/a
PE Ratio
44.52
Stock Price
44.47
Market Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 7.73B, a decrease of -42.74%. That is a compound annual growth rate of -11.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 7.73B | -14.45% |
| Dec 31, 2025 | 9.04B | 71.05% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
| Oct 18, 2021 | 13.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 8.40B |
| Zhejiang Ausun Pharmaceutical | 8.38B |
| Bio-Thera Solutions | 8.30B |
| Nanjing Vazyme Biotech | 8.10B |
| Shanghai Medicilon | 8.06B |
| Chengdu Kanghua Biological Products | 7.55B |
| Suzhou Fengbei Biotech Stock | 7.28B |
| Jiangsu Aidea Pharmaceutical Group | 7.23B |